[1]
T. PRABHA and T. SIVAKUMAR 2018. Drug design and in-silico study of sulphadiazine schiff base analogues for their potential claim as anti-my cobacterial ligand. International Journal of Pharma and Bio Sciences. 9, 3 (Sep. 2018), 106–112. DOI:https://doi.org/10.22376/ijpbs.2018.9.3.p106-112.